Eugenio Morelli

2.6k total citations
55 papers, 1.5k citations indexed

About

Eugenio Morelli is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Eugenio Morelli has authored 55 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 38 papers in Hematology and 14 papers in Oncology. Recurrent topics in Eugenio Morelli's work include Multiple Myeloma Research and Treatments (38 papers), Protein Degradation and Inhibitors (20 papers) and Peptidase Inhibition and Analysis (11 papers). Eugenio Morelli is often cited by papers focused on Multiple Myeloma Research and Treatments (38 papers), Protein Degradation and Inhibitors (20 papers) and Peptidase Inhibition and Analysis (11 papers). Eugenio Morelli collaborates with scholars based in United States, Italy and China. Eugenio Morelli's co-authors include Pierfrancesco Tassone, Nicola Amodio, Nikhil C. Munshi, Annamaria Gullà, Marco Rossi, Maria Teresa Di Martino, Pierosandro Tagliaferri, Kenneth C. Anderson, Antonino Neri and Mariateresa Fulciniti and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Eugenio Morelli

52 papers receiving 1.5k citations

Peers

Countries citing papers authored by Eugenio Morelli

Since Specialization

Citations

This map shows the geographic impact of Eugenio Morelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugenio Morelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugenio Morelli more than expected).

Fields of papers citing papers by Eugenio Morelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugenio Morelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugenio Morelli. The network helps show where Eugenio Morelli may publish in the future.

Co-authorship network of co-authors of Eugenio Morelli

This figure shows the co-authorship network connecting the top 25 collaborators of Eugenio Morelli. A scholar is included among the top collaborators of Eugenio Morelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugenio Morelli. Eugenio Morelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of the LINE1-derived MET transcript induces apoptosis and oncoprotein knockdown in cancer cells 2025 ·Molecular Therapy — Nucleic Acids ·Umberto Miglio, Enrico Berrino, Daniele Avanzato, Ivan Molineris, Valentina Miano, (unknown), Letizia Lanzetti, Eugenio Morelli, James M. Hughes, Michele De Bortoli, Anna Sapino, Tiziana Venesio	0
2	Loss of BCL7A permits IRF4 transcriptional activity and cellular growth in multiple myeloma 2025 ·Blood ·(unknown), Srikanth Talluri, Moritz Binder, Eugenio Morelli, Jessica Encinas, (unknown), Anıl Aktaş Samur, Charles B. Epstein, (unknown), Masood A. Shammas, Mehmet Samur, Mariateresa Fulciniti, Nikhil Munshi	1
3	<i>DIS3</i> depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification 2023 ·Haematologica ·(unknown), Domenica Ronchetti, Ilaria Silvestris, (unknown), G. Fabbiano, (unknown), (unknown), Silvia Erratico, Alessia Ciarrocchi, Valentina Fragliasso, (unknown), (unknown), Raffaella Chiaramonte, Yvan Torrente, Palma Finelli, Eugenio Morelli, Nikhil C. Munshi, Niccolò Bolli, Antonino Neri, Elisa Taìana	5
4	RAD51 Is Required for the Occupancy of Replication Licensing Factors on the Myeloma Genome 2023 ·Blood ·(unknown), Srikanth Talluri, Subodh Kumar, Eugenio Morelli, (unknown), Masood A. Shammas, Nikhil C. Munshi	1
5	CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma 2023 ·Blood ·Yao Yao, (unknown), (unknown), Mehmet Samur, Eugenio Morelli, Jessica Encinas, Zuzana Chyra, Yan Xu, (unknown), Charles B. Epstein, Behnam Nabet, Marta Chesi, Nathanael S. Gray, Richard A. Young, Nicholas Kwiatkowski, Constantine S. Mitsiades, Kenneth C. Anderson, Charles Y. Lin, Nikhil C. Munshi, Mariateresa Fulciniti	17
6	GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 2023 ·Cells ·Maria Eugenia Gallo Cantafio, (unknown), Francesca Scionti, Maria Mesuraca, Domenica Ronchetti, Mariaelena Pistoni, Dina Bellizzi, Giuseppe Passarino, Eugenio Morelli, Antonino Neri, Giuseppe Viglietto, Nicola Amodio	6
7	Aberrant Expression of Spliced WNK2 Is an Early Event in MYD88 Mutated WM That Activates ERK1/2 and Supports Tumor Growth 2023 ·Blood ·Maria Luisa Guerrera, Zachary R. Hunter, (unknown), Nickolas Tsakmaklis, Amanda Kofides, Shirong Liu, Christopher J. Patterson, Eugenio Morelli, Jorge J. Castillo, Shayna Sarosiek, Catherine Flynn, Kirsten Meid, Andrew R. Branagan, Ruben D. Carrasco, Kenneth C. Anderson, Nikhil C. Munshi, Steven P. Treon, Xia Liu	1
8	BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma 2023 ·Clinical Cancer Research ·Keiji Kurata, Mehmet Samur, (unknown), Kenneth Wen, (unknown), Jiye Liu, Eugenio Morelli, Annamaria Gullà, Yu‐Tzu Tai, Jun Qi, Teru Hideshima, Kenneth C. Anderson	19
9	Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation 2021 ·Blood Cancer Discovery ·Annamaria Gullà, Eugenio Morelli, Mehmet Samur, Cirino Botta, Teru Hideshima, Giada Bianchi, Mariateresa Fulciniti, (unknown), Rao Prabhala, Srikanth Talluri, Kenneth Wen, Yu‐Tzu Tai, Paul G. Richardson, Dharminder Chauhan, Tomasz Sewastianik, Ruben D. Carrasco, Nikhil C. Munshi, Kenneth C. Anderson	92
10	CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network 2021 ·Methods in molecular biology ·Eugenio Morelli, Annamaria Gullà, Nicola Amodio, Elisa Taìana, Antonino Neri, Mariateresa Fulciniti, Nikhil C. Munshi	16
11	In Vitro Silencing of lncRNAs Using LNA GapmeRs 2021 ·Methods in molecular biology ·Elisa Taìana, (unknown), Domenica Ronchetti, Eugenio Morelli, Pierfrancesco Tassone, Giuseppe Viglietto, Nikhil C. Munshi, Antonino Neri, Nicola Amodio	5
12	The Non-Coding RNA Landscape of Plasma Cell Dyscrasias 2020 ·Cancers ·Eugenio Morelli, Annamaria Gullà, Roberta Rocca, Cinzia Federico, Lavinia Raimondi, (unknown), Valter Agosti, Marco Rossi, Giosuè Costa, Gianluca Giavaresi, Abdel Kareem Azab, Antonia Cagnetta, Michele Cea, Pierosandro Tagliaferri, Antonino Neri, Nikhil C. Munshi, Giuseppe Viglietto, Pierfrancesco Tassone, Nicola Amodio	25
13	Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 2020 ·Haematologica ·Daniele Caracciolo, Francesca Scionti, Giada Juli, Emanuela Altomare, Gaetanina Golino, Katia Todoerti, Katia Grillone, Caterina Riillo, Mariamena Arbitrio, Michelangelo Iannone, Eugenio Morelli, Nicola Amodio, Maria Teresa Di Martino, Marco Rossi, Antonino Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone	34
14	Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 2018 ·Leukemia ·Nicola Amodio, Maria Angelica Stamato, Giada Juli, Eugenio Morelli, Mariateresa Fulciniti, Martina Manzoni, Elisa Taìana, Luca Agnelli, Maria Eugenia Gallo Cantafio, Enrica Romeo, Lavinia Raimondi, Daniele Caracciolo, Valeria Zuccalà, Marco Rossi, Antonino Neri, Nikhil C. Munshi, Pierosandro Tagliaferri, Pierfrancesco Tassone	204
15	Th17 Cells Targeting By MiR-21 Inhibitor Impairs Multiple Myeloma Related Bone Disease 2017 ·Blood ·Marco Rossi, Emanuela Altomare, Nicola Amodio, Maria Teresa Di Martino, Marco Gaspari, Domenico Taverna, Domenica Scumaci, Francesco Conforti, Daniele Caracciolo, Cirino Botta, Cinzia Federico, Annamaria Gullà, Eugenio Morelli, Francesca Scionti, Mariamena Arbitrio, (unknown), Antonino Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone	2
16	Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma 2016 ·Molecular Cancer Therapeutics ·Nicola Amodio, Maria Angelica Stamato, Annamaria Gullà, Eugenio Morelli, Enrica Romeo, Lavinia Raimondi, Maria Rita Pitari, Ida Ferrandino, Gabriella Misso, Michele Caraglia, Ida Perrotta, Antonino Neri, Mariateresa Fulciniti, Christian Rolfo, Kenneth C. Anderson, Nikhil C. Munshi, Pierosandro Tagliaferri, Pierfrancesco Tassone	96
17	A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells 2015 ·Clinical Cancer Research ·Annamaria Gullà, Maria Teresa Di Martino, Maria Eugenia Gallo Cantafio, Eugenio Morelli, Nicola Amodio, Cirino Botta, Maria Rita Pitari, (unknown), Domenico Britti, Maria Angelica Stamato, Teru Hideshima, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri, Pierfrancesco Tassone	97
18	Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo 2015 ·Leukemia ·Eugenio Morelli, Emanuela Leone, Maria Eugenia Gallo Cantafio, Maria Teresa Di Martino, Nicola Amodio, Lavinia Biamonte, Annamaria Gullà, Umberto Foresta, Maria Rita Pitari, Cirino Botta, Marco Rossi, Antonino Neri, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri, Pierfrancesco Tassone	93
19	In Vitro and In Vivo Activity of a Novel Locked Nucleic Acid (LNA)-Inhibitor-miR-221 against Multiple Myeloma Cells 2014 ·PLoS ONE ·Maria Teresa Di Martino, Annamaria Gullà, Maria Eugenia Gallo Cantafio, Emanuela Altomare, Nicola Amodio, Emanuela Leone, Eugenio Morelli, (unknown), Daniele Caracciolo, Marco Rossi, Niels Frandsen, Pierosandro Tagliaferri, Pierfrancesco Tassone	74
20	Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth 2013 ·Clinical Cancer Research ·Emanuela Leone, Eugenio Morelli, Maria Teresa Di Martino, Nicola Amodio, Umberto Foresta, Annamaria Gullà, Marco Rossi, Antonino Neri, Antonio Giordano, Nikhil C. Munshi, Kenneth C. Anderson, Pierosandro Tagliaferri, Pierfrancesco Tassone	184

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact